Abstract
Approximately 50% of patients with metastatic disease develop a malignant pleural effusion (MPE). Prompt clinical evaluation and treatment to achieve successful palliation are the main goals of management of MPE. Optimal treatment is still controversial and there is no universal standard approach. Management options include observation, thoracentesis, indwelling pleural catheter (IPC) or chest tube placement, pleurodesis, and surgical pleurectomy. The treatment for each patient should be based on symptoms, general condition, and life expectancy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 731-738 |
| Number of pages | 8 |
| Journal | Journal of Surgical Oncology |
| Volume | 105 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jun 1 2012 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Surgery
- Oncology
Fingerprint
Dive into the research topics of 'Multidisciplinary management of malignant pleural effusion'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver